Helen Torley, President and CEO at Halozyme Therapeutics, sold HALO on Oct 8, 2026
Data as of Oct 16
- Traded
- Oct 8, 2026
- Disclosed
- Oct 8, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
HALO since disclosure
+10.9%
after the sale
Similar stocks (XLV) since disclosure
+5.1%
XLV — its sector index fund
Change in closing price from Oct 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.3Mdisclosed Oct 8 · filed the same day
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$22.1Kdisclosed Oct 8 · filed the same day
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$337Kdisclosed Oct 8 · filed the same day
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$955Kdisclosed Oct 8 · filed 1 day after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.2Mdisclosed Oct 8 · filed 1 day after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$102Kdisclosed Oct 8 · filed 1 day after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$22.7Kdisclosed Oct 8 · filed 1 day after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$656Kdisclosed Oct 8 · filed 2 days after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$197Kdisclosed Oct 8 · filed 2 days after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.1Mdisclosed Oct 8 · filed 2 days after the trade
- ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$248Kdisclosed Oct 8 · filed 2 days after the trade